Date Filed | Type | Description |
04/15/2020 |
SC 13D/A
| Altiva Management Inc. reports a 9.3% stake in Progenics Pharmaceuticals, Inc. |
04/09/2020 |
SC 13D/A
| Altiva Management Inc. reports a 9.3% stake in Progenics Pharmaceuticals, Inc. |
11/12/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/08/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
11/05/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
11/04/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/28/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/24/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/23/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/22/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/21/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/18/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/16/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/11/2019 |
DFRN14A
| Form DFRN14A - Revised definitive proxy statement filed by non-management: |
10/08/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
10/07/2019 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
10/02/2019 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
10/02/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
09/30/2019 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
09/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/18/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
09/18/2019 |
PREC14A
| Form PREC14A - Preliminary proxy statements, contested solicitations: |
09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/05/2019 |
4
| Velan Capital, L.P. (10% Owner) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns:
| Bought 277,424 shares
@ $4.3937, valued at
$1.2M
Bought 243,614 shares
@ $4.5093, valued at
$1.1M
|
|
08/27/2019 |
4
| Velan Capital, L.P. (10% Owner) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns:
| Bought 130,826 shares
@ $4.3087, valued at
$563.7k
Bought 73,230 shares
@ $4.3003, valued at
$314.9k
|
|
08/27/2019 |
3
| Velan Capital, L.P. (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC |
08/26/2019 |
SC 13D/A
| Altiva Management Inc. reports a 8.6% stake in Progenics Pharmaceuticals, Inc. |
07/22/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
07/08/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
07/01/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
06/28/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
06/28/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
06/25/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
06/20/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
|